Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee045792c233850caea514665029be19 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10123 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10122 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 |
filingDate |
2003-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e13076e6a7c6a043f6f9c1677ed428c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f04c036a22ea8c6d012cca29540dc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2e39c20bb8f199d8d133eea7f6dcb13 |
publicationDate |
2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006166187-A1 |
titleOfInvention |
Hbv precore protein capable of forming particles |
abstract |
There is provided a HBV precore protein having an ability of forming particles, and a means for determining it. A novel HBV precore protein that forms the virus (like) particles of HBV was identified. The present invention provides this novel HBV precore protein. Furthermore, there are provided core-like particles and virus-like particles formed by this HBV precore protein. These virus-like particles can be used for vaccines and therapeutic agents. The present invention also provides a method of determining the HBV precore protein and a method of determining the anti-HBV precore protein antibody. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9952217-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8216589-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011165194-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007264646-A1 |
priorityDate |
2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |